Registry of Lobbyists
Version 6 of 8 (1999-03-11 to 1999-10-13) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Organization: |
CANADIAN SOCIETY OF HOSPITAL PHARMACISTS (CSHP)
350 - 1145 HUNT CLUB ROAD OTTAWA, ON K1V 0Y3 Canada |
| Telephone number: | 613-736-9733 |
| Fax number: | 613-736-5660 |
| Responsible officer name and position during the period of this registration: | WILLIAM J LESLIE, EXECUTIVE DIRECTOR |
| Description of the organization's activities: | THE CANADIAN SOCIETY OF HOSPITAL PHARMACISTS (CSHP) IS THE NATIONAL VOLUNTARY ORGANIZATION OF PHARMACISTS WHO SHARE AN INTEREST IN PHARMACY PRACTICE IN HOSPITALS AND RELATED HEALTH CARE SETTINGS.CSHP'S VISION IS : PHARMACISTS IN DIVERSE PRACTICES....FORGING PARTNERSHIPS, REACHING OUT TO HELP PATIENTS, ...MAKING A DIFFERENCE!RELATED VISION OBJECTIVES:1) GAIN EXTERNAL RECOGNITION AND SUPPORT FOR THE DIRECT PATIENT CARE ROLE OF THE PHARMACIST.2) PROVIDE SUPPORT TO MEMBERS IN THEIR DIRECT PATIENT CARE ROLE THROUGH EDUCATION, SKILLS DEVELOPMENT AND PRACTICE TOOLS.3) FOSTER AN ENVIRONMENT THAT FACILITATES THE DIVERSE ROLE OF THE PHARMACIST |
| Organization's membership or classes of membership: | 1- ACTIVE MEMBERS ARE PHARMACISTS LICENSED OR REGISTERED WITH A PHARMACY REGULATORY BODY IN CANADA OR PERSONS WITH A PROFESSIONAL DEGREE IN PHARMACY2- HONORARY MEMBERS - ELECTED BY A 2/3 VOTE OF THE COUNCIL OF THE SOCIETY3- STUDENT MEMBERS ARE PERSONS ENROLLED IN A BACCALAUREATE DEGREE PROGRAM IN PHARMACY4- SUPPORTING MEMBERS ARE PERSONS NOT ELIGIBLE FOR OTHER MEMBERSHIP CATEGORIES5- CORPORATE MEMBERS ARE CORPORATIONS WHO SUPPORT THE OBJECTIVES OF AND PAY FEES TO THE SOCIETY |
| Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | WILLIAM LESLIE |
| Position title: | EXECUTIVE DIRECTOR |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Environment Canada, Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Health |
| Subject Matter: Retrospective: | CONTINUED WITH WORK WITH TPP (THERAPEUTIC PRODUCTS PROGRAMME) ON COMPOUNDING VS MANUFACTURING.RESPONSES TO REQUESTS FOR COMMENT :TPP : MEDICAL DEVICES COST RECOVERY; CONTROLLED DRUG & SUBSTANCE ACT EXEMPTIONS; SCHEDULE A AMMENDMENT RE: HEPATITIS; PRESCRIPTION TO OTC SWITCH OF ACETOMINOPHEN 650MG; SURVEY ON TPP OPERATIONS; POLICY ON DISENFECTANTS & SANITIZERS; PRESCRIPTION TO OTC SWITCH OF MECHLIZINE; SURVEY ON TPP BUREAU OF DRUG SURVEILLANCE CONTINUING ASSESSMENT DIVISION;CONTINUED PARTICIPATION ON TPP APETI (ADVISORY PANEL ELECT. TRANS. INFORM)REPRESENT CSHP AT TPP ASSOCIATION PRINCIPLAS MEETINGSUPPORT MEMBER REQUEST TO TPP FOR ACTION ON LATEX ALLERGY ISSUESCONTACT HEALTH CAN TO REQUEST INVITATION TO PARTICIPATE ON HC/CMA ROUNDTABLE ON BEST PRESCRIBING PRACTICESCONTACT OFFICE OF MINISTER OF HELATH FOR MEETING TO DISCUSS MEDICATION ERROR REPORTING SYSTEM FOR CANADAREPRESENT CSHP AT TPP INVITATIONAL MEETING ON COST RECOVERY PHASE IV |
| Subject Matter: Prospective: | CONTINUED WITH WORK WITH TPP (THERAPEUTIC PRODUCTS PROGRAMME) ON COMPOUNDING VS MANUFACTURING.RESPONSES TO REQUESTS FOR COMMENT :TPP : MEDICAL DEVICES COST RECOVERY; CONTROLLED DRUG & SUBSTANCE ACT EXEMPTIONS; SCHEDULE A AMMENDMENT RE: HEPATITIS; PRESCRIPTION TO OTC SWITCH OF ACETOMINOPHEN 650MG; SURVEY ON TPP OPERATIONS; POLICY ON DISENFECTANTS & SANITIZERS; PRESCRIPTION TO OTC SWITCH OF MECHLIZINE; SURVEY ON TPP BUREAU OF DRUG SURVEILLANCE CONTINUING ASSESSMENT DIVISION;CONTINUED PARTICIPATION ON TPP APETI (ADVISORY PANEL ELECT. TRANS. INFORM)REPRESENT CSHP AT TPP ASSOCIATION PRINCIPLAS MEETINGSUPPORT MEMBER REQUEST TO TPP FOR ACTION ON LATEX ALLERGY ISSUESCONTACT HEALTH CAN TO REQUEST INVITATION TO PARTICIPATE ON HC/CMA ROUNDTABLE ON BEST PRESCRIBING PRACTICESCONTACT OFFICE OF MINISTER OF HELATH FOR MEETING TO DISCUSS MEDICATION ERROR REPORTING SYSTEM FOR CANADAREPRESENT CSHP AT TPP INVITATIONAL MEETING ON COST RECOVERY PHASE IVRESPONSE TO SCIENCE ADVISORY BOARD REVIEW OF TPP DRUG REVIEW PROCESS. |